THC · NYSE · CIK 0000070318

TENET HEALTHCARE CORP

TENET HEALTHCARE CORP’s most recent SEC filing in our snapshot is a Form 8-K filed on Sep 22, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $21.3B and net income of $2.4B, according to its XBRL data on EDGAR. Its EDGAR record lists 63 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$21.3B
Net income, FY2025
$2.4B
Form 4 filings on record, past 12 months
63

Company overview

Legal name (as filed)
TENET HEALTHCARE CORP
Ticker
THC
SEC Central Index Key (CIK)
0000070318
Business address
DALLAS, TX
State or country of incorporation
NV
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#571 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from TENET HEALTHCARE CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$19.5BFY2021$19.2BFY2022$20.6BFY2023$20.7BFY2024$21.3BFY2025
Net income
$1.5BFY2021$1.0BFY2022$1.3BFY2023$4.1BFY2024$2.4BFY2025
THC annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$19.5B$19.2B$20.6B$20.7B$21.3B
Net income$1.5B$1.0B$1.3B$4.1B$2.4B
Diluted EPS$8.42$3.79$5.71$32.70$15.49
Total assets$27.6B$27.2B$28.3B$28.9B$29.7B
Cash and equivalents$2.4B$858.0M$1.2B$3.0B$2.9B

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

THC latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 17, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 29, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Sep 22, 20268-KMaterial agreement; New financial obligation· period Sep 22, 2026Document · Index
Apr 16, 2026DEF 14ADefinitive proxy statement· period May 27, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about TENET HEALTHCARE CORP, by form type:

4 ×18144 ×148-K ×4SCHEDULE 13G/A ×310-Q ×1
THC recent filings
FiledFormWhat it isOriginal
Sep 22, 20268-KMaterial agreement; New financial obligation· period Sep 22, 2026Document · Index
Sep 16, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 14, 2026Document · Index
Sep 14, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 14, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 10, 2026Document · Index
Sep 10, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 8, 20268-KRegulation FD disclosure; Other events· period Sep 8, 2026Document · Index
Sep 4, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026Document · Index
Sep 2, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 31, 2026Document · Index
Aug 31, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 31, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 28, 2026Document · Index
Aug 26, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 24, 2026Document · Index
Aug 26, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 24, 2026Document · Index
Aug 25, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 24, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 24, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 7, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 7, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 5, 2026Document · Index
Aug 6, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 5, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 31, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 29, 2026Document · Index
Jul 29, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 29, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026Document · Index
Jul 27, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 27, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 23, 20268-KResults of operations· period Jul 23, 2026Document · Index
May 29, 20264Statement of changes in beneficial ownership (insider trade)· period May 28, 2026Document · Index
May 29, 20268-KShareholder vote results· period May 27, 2026Document · Index
May 28, 2026144Notice of proposed sale of securitiesDocument · Index
May 28, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 28, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 28, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index
May 28, 20264Statement of changes in beneficial ownership (insider trade)· period May 27, 2026Document · Index

Insider filing activity

63 Form 4 filings appear in TENET HEALTHCARE CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-General Medical & Surgical Hospitals, NEC

All 5 companies in Services-General Medical & Surgical Hospitals, NEC· Companies headquartered in Texas

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000070318 and XBRL company facts. TENET HEALTHCARE CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.